EMA Application withdrawn: Loulla — Only For Children Pharmaceuticals

View source ↗

Summary

The EMA withdrew the application for Loulla from Only For Children Pharmaceuticals for a leukemia/lymphoid therapeutic area.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoid Leukemia

Drugs mentioned

• Loulla (mercaptopurine)

Snippet

Status: Application withdrawn. Therapeutic area: Leukemia, Lymphoid. MAH: Only For Children Pharmaceuticals. Decision date: 18/01/2013. Orphan medicine